Literature DB >> 34643971

Microglia-specific ApoE knock-out does not alter Alzheimer's disease plaque pathogenesis or gene expression.

Caden M Henningfield1, Miguel A Arreola1, Neelakshi Soni1, Elizabeth E Spangenberg1, Kim N Green1.   

Abstract

Previous studies suggest that microglial-expressed Apolipoprotein E (ApoE) is necessary to shift microglia into a neurodegenerative transcriptional state in Alzheimer's disease (AD) mouse models. On the other hand, elimination of microglia shifts amyloid beta (Aβ) accumulation from parenchymal plaques to cerebral amyloid angiopathy (CAA), mimicking the effects of global APOE*4 knock-in. Here, we specifically knock-out microglial-expressed ApoE while keeping astrocytic-expressed ApoE intact. When microglial-specific ApoE is knocked-out of a 5xFAD mouse model of AD, we found a ~35% increase in average Aβ plaque size, but no changes in plaque load, microglial number, microglial clustering around Aβ plaques, nor the formation of CAA. Immunostaining revealed ApoE protein present in plaque-associated microglia in 5xFAD mice with microglial-specific ApoE knockout, suggesting that microglia can take up ApoE from other cellular sources. Mice with Apoe knocked-out of microglia had lower synaptic protein levels than control mice, indicating that microglial-expressed ApoE may have a role in synapse maintenance. Surprisingly, microglial-specific ApoE knock-out resulted in few differentially expressed genes in both 5xFAD and control mice; however, some rescue of 5xFAD associated neuronal networks may occur with microglial-specific ApoE knock-out as shown by weighted gene co-expression analysis. Altogether, our data indicates that microglial-expressed ApoE may not be necessary for plaque formation or for the microglial transcriptional shift into a Disease Associated Microglia state that is associated with reactivity to plaques but may be necessary for plaque homeostasis in disease and synaptic maintenance under normal conditions.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  Alzheimer's disease; Apolipoprotein E; amyloid; inflammation; microglia

Mesh:

Substances:

Year:  2021        PMID: 34643971      PMCID: PMC9308171          DOI: 10.1002/glia.24105

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   8.073


  70 in total

1.  Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.

Authors:  Elizabeth E Spangenberg; Rafael J Lee; Allison R Najafi; Rachel A Rice; Monica R P Elmore; Mathew Blurton-Jones; Brian L West; Kim N Green
Journal:  Brain       Date:  2016-02-26       Impact factor: 13.501

2.  Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2).

Authors:  Yuka Atagi; Chia-Chen Liu; Meghan M Painter; Xiao-Fen Chen; Christophe Verbeeck; Honghua Zheng; Xia Li; Rosa Rademakers; Silvia S Kang; Huaxi Xu; Steven Younkin; Pritam Das; John D Fryer; Guojun Bu
Journal:  J Biol Chem       Date:  2015-09-15       Impact factor: 5.157

3.  Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse.

Authors:  Ye Zhang; Steven A Sloan; Laura E Clarke; Christine Caneda; Colton A Plaza; Paul D Blumenthal; Hannes Vogel; Gary K Steinberg; Michael S B Edwards; Gordon Li; John A Duncan; Samuel H Cheshier; Lawrence M Shuer; Edward F Chang; Gerald A Grant; Melanie G Hayden Gephart; Ben A Barres
Journal:  Neuron       Date:  2015-12-10       Impact factor: 17.173

Review 4.  Biomarker modeling of Alzheimer's disease.

Authors:  Clifford R Jack; David M Holtzman
Journal:  Neuron       Date:  2013-12-18       Impact factor: 17.173

5.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

Authors:  A M Saunders; W J Strittmatter; D Schmechel; P H George-Hyslop; M A Pericak-Vance; S H Joo; B L Rosi; J F Gusella; D R Crapper-MacLachlan; M J Alberts
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

6.  Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.

Authors:  P Tiraboschi; L A Hansen; E Masliah; M Alford; L J Thal; J Corey-Bloom
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

7.  Single-cell transcriptomic analysis of Alzheimer's disease.

Authors:  Hansruedi Mathys; Jose Davila-Velderrain; Zhuyu Peng; Fan Gao; Shahin Mohammadi; Jennie Z Young; Madhvi Menon; Liang He; Fatema Abdurrob; Xueqiao Jiang; Anthony J Martorell; Richard M Ransohoff; Brian P Hafler; David A Bennett; Manolis Kellis; Li-Huei Tsai
Journal:  Nature       Date:  2019-05-01       Impact factor: 49.962

8.  Global quantitative analysis of the human brain proteome in Alzheimer's and Parkinson's Disease.

Authors:  Lingyan Ping; Duc M Duong; Luming Yin; Marla Gearing; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Sci Data       Date:  2018-03-13       Impact factor: 6.444

9.  Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model.

Authors:  Yang Shi; Melissa Manis; Justin Long; Kairuo Wang; Patrick M Sullivan; Javier Remolina Serrano; Rosa Hoyle; David M Holtzman
Journal:  J Exp Med       Date:  2019-10-10       Impact factor: 14.307

10.  TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.

Authors:  Cheryl E G Leyns; Jason D Ulrich; Mary B Finn; Floy R Stewart; Lauren J Koscal; Javier Remolina Serrano; Grace O Robinson; Elise Anderson; Marco Colonna; David M Holtzman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

View more
  7 in total

Review 1.  Astrocytes in Neurodegeneration: Inspiration From Genetics.

Authors:  Jingxuan Huang; Chunyu Li; Huifang Shang
Journal:  Front Neurosci       Date:  2022-06-24       Impact factor: 5.152

Review 2.  APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease.

Authors:  Samira Parhizkar; David M Holtzman
Journal:  Semin Immunol       Date:  2022-02-26       Impact factor: 10.671

Review 3.  Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer's Disease.

Authors:  Yi-Jun Xu; Ngan Pan Bennett Au; Chi Him Eddie Ma
Journal:  Front Aging Neurosci       Date:  2022-05-26       Impact factor: 5.702

Review 4.  Synapses, Microglia, and Lipids in Alzheimer's Disease.

Authors:  Patrick J Paasila; Jason A Aramideh; Greg T Sutherland; Manuel B Graeber
Journal:  Front Neurosci       Date:  2022-01-12       Impact factor: 4.677

5.  Cortical diurnal rhythms remain intact with microglial depletion.

Authors:  Rocio A Barahona; Samuel Morabito; Vivek Swarup; Kim N Green
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

Review 6.  The aging immune system in Alzheimer's and Parkinson's diseases.

Authors:  Kelsey S Heavener; Elizabeth M Bradshaw
Journal:  Semin Immunopathol       Date:  2022-05-03       Impact factor: 11.759

7.  Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.

Authors:  Thomas E Mahan; Chao Wang; Xin Bao; Ankit Choudhury; Jason D Ulrich; David M Holtzman
Journal:  Mol Neurodegener       Date:  2022-02-02       Impact factor: 14.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.